Barclays Sees 22% Upside For AbbVie On Humira Opportunity By: Benzinga via Benzinga July 02, 2014 at 09:57 AM EDT In a report published Tuesday, Barclays analyst Mark Purcell downgraded the sector view for U.S. Pharma majors from Positive to ... Read More >> Related Stocks: AbbVie